WARFARIN SUCRALFATE INTERACTION IS POSSIBLE

被引：0
|
作者：
DARCY, PF
机构：
来源：
PHARMACY INTERNATIONAL | 1983年 / 4卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [21] Possible warfarin failure due to interaction with smokeless tobacco
    Kuykendall, JR
    Houle, MD
    Rhodes, RS
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (04) : 595 - 597
  • [22] STUDIES OF POSSIBLE THERAPEUTIC INTERACTION BETWEEN CYCLAMATE AND WARFARIN
    HOLCENBERG, JS
    BIDGOOD, M
    DIXON, RL
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1969, 11 (09): : 577 - +
  • [23] Possible interaction between warfarin and cranberry juice - In reply
    Lynch, D
    AMERICAN FAMILY PHYSICIAN, 2005, 72 (06) : 1000 - 1000
  • [24] Retrospective evaluation of a possible interaction between warfarin and levofloxacin
    McCall, KL
    Scott, JC
    Anderson, HG
    PHARMACOTHERAPY, 2005, 25 (01): : 67 - 73
  • [25] EFFECT OF SUCRALFATE ON PLASMA WARFARIN CONCENTRATION IN PATIENTS REQUIRING CHRONIC WARFARIN THERAPY
    TALBERT, RL
    DALMADYISRAEL, C
    BUSSEY, HI
    CRAWFORD, MH
    LUDDEN, TM
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (06): : 456 - 457
  • [26] Warfarin and phenytoin drug interaction with possible purple glove syndrome
    Hunter, Carolyn S.
    Phan, Stephanie V.
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2016, 7 (02) : 96 - 98
  • [27] Possible interaction between warfarin and Lycium barbarum L.
    Lam, AY
    Elmer, GW
    Mohutsky, MA
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (10) : 1199 - 1201
  • [28] POSSIBLE INTERACTION OF ROXITHROMYCIN WITH WARFARIN - UPDATED REVIEW OF ADR REPORTS
    GHOSE, K
    ASHTON, J
    ROHAN, A
    CLINICAL DRUG INVESTIGATION, 1995, 10 (05) : 302 - 309
  • [29] Drug point - Possible interaction between warfarin and cranberry juice
    Suvarna, R
    Pirmohamed, M
    Henderson, L
    BRITISH MEDICAL JOURNAL, 2003, 327 (7429): : 1454 - 1454
  • [30] RANITIDINE SUCRALFATE INTERACTION STUDY
    MACONOCHIE, JG
    THOMAS, M
    MICHAEL, MF
    JENNER, WR
    TANNER, RJN
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 205 - 205
12345